Webdisclosure.com

Search

ESPERITE (AMS:ESP) ESPERITE N.V. (ESP) publishes its half-year report. Revenues, results and consolidated equity were impacted by adverse market conditions on the stem cell business.

Directive transparence : information réglementée

30/06/2019 21:01